Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.41M Sell
4,731
-3
-0.1% -$4.78K 3.33% 12
2026
Q1
$6.25M Sell
4,734
-36
-0.8% -$49.3K 2.4% 21
2025
Q4
$5.1M Hold
4,770
1.9% 23
2025
Q3
$4.62M Sell
4,770
-86
-2% -$67.6K 1.7% 23
2025
Q2
$3.89M Buy
4,856
+44
+0.9% +$31.6K 1.5% 25
2025
Q1
$3.19M Buy
4,812
+294
+7% +$214K 1.24% 26
2024
Q4
$3.13M Buy
4,518
+123
+3% +$88.3K 1.31% 25
2024
Q3
$3.66M Buy
4,395
+1,037
+31% +$927K 1.49% 25
2024
Q2
$3.43M Hold
3,358
1.48% 24
2024
Q1
$3.26M Hold
3,358
1.38% 25
2023
Q4
$2.54M Buy
3,358
+30
+0.9% +$19.8K 1.19% 26
2023
Q3
$1.96M Buy
3,328
+5
+0.2% +$3.32K 0.95% 28
2023
Q2
$2.41M Buy
3,323
+50
+2% +$34K 1.1% 28
2023
Q1
$2.23M Hold
3,273
1.08% 27
2022
Q4
$1.79M Sell
3,273
-885
-21% -$464K 0.91% 29
2022
Q3
$1.73M Hold
4,158
0.91% 31
2022
Q2
$1.98M Sell
4,158
-10
-0.2% -$5.58K 0.94% 31
2022
Q1
$2.78M Buy
+4,168
New +$2.79M 1.1% 29

Other funds holding ASML

Thomas Story & Son's ASML Position: Q2 2026 in Review

Thomas Story & Son reduced its ASML (ASML) stake by 0.06% in Q2 2026, selling an estimated $4.78K and leaving 4,731 shares worth $9.41M. The position accounts for 3.33% of the portfolio, ranked #12.

Thomas Story & Son first reported a position in ASML in Q1 2022 and has held it in 18 quarters since. 1,099 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Thomas Story & Son held 4,731 shares of ASML worth $9.41M as of Q2 2026.
  • Thomas Story & Son sold 3 ASML shares in Q2 2026, an estimated $4.78K.
  • ASML made up 3.33% of Thomas Story & Son's portfolio in Q2 2026, its #12 holding.
  • Thomas Story & Son first reported a position in ASML in Q1 2022 and has held it in 18 quarters since.
  • 1,099 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Thomas Story & Son's 13F filing for Q2 2026, filed 23 Jul 2026.